Searchable abstracts of presentations at key conferences on calcified tissues

ba0005p364 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Peak bone mass and quantitative ultrasound bone properties in young adulthood: a study in the PEAK-25 cohort

Sandstrom Linnea , McGuigan Fiona , Callreus Mattias , Akesson Kristina

Peak bone mass, typically reached in the third decade, is the highest bone mass acquired after completion of normal growth. Attaining a higher young adult bone mass may contribute to a lower risk of fragility fractures later in life. Few studies have specifically investigated quantitative ultrasound (QUS) in relation to peak bone mass in young adult women. The study objectives were to describe normative QUS values for 25 year old women and how extremes of body weight relate to...

ba0007p120 | (1) | ICCBH2019

Mutational and phenotypic spectra in 137 Russian patients with inherited forms of rickets

Kulikova Kristina , Kolodkina Anna , Vasiliev Evgeny , Petrov Vasiliy , Tiulpakov Anatoly

Background: Inherited forms of rickets are metabolic bone diseases developing as a result of inadequate mineralization of a growing bone due to disruption of calcium, phosphorus and/or vitamin D metabolism. Diverse phenotypic presentation and aetiology of these disorders pose difficulties for the diagnosis and management.Objective and hypotheses: The aim of this study was to perform molecular diagnostics and clinically characterize 137 patients with here...

ba0001pp153 | Cancer and bone: basic, translational and clinical | ECTS2013

The DXA results in 41 patients with neuroendocrine tumors: a transversal study

Carsote Mara , Geleriu Andreea , Dusceac Roxana , Miron Roxana , Ene Cristina , Radoi Valentin , Voicu Gabriela , Poiana Catalina

Different results might be registered in DXA assessment in patients with neuroendocrine tumors (NET) since various factors induce bone disturbances as bone metastases, vitamin D hypovitaminosis, etc.Aim: The analyze DXA in NET.Material and method: The patients (p) were evaluated between 2008 and 2013. The diagnosis of NET was histological confirmed. We also included medullar thyroid cancer (MTC) with distance metastases and carcino...

ba0001pp331 | Osteoporosis: evaluation and imaging | ECTS2013

May we screen with FRAX clinical factors?

Barbu Carmen Gabriela , Poiana Catalina , Ionita Dariana , Gascan Magda , Stefan Cristina , Stefanopol Aurelia , Fica Simona

Aim: The aim of the study was to evaluate the usefulness of the fracture risk evaluated through the FRAX® model based only on the clinical risk factors as a screening tool for identify the target population for treatment in osteoporosis.Materials and methods: Two hundred and seventy-six postmenopausal women treatment naive referred to two different endocrinology departments for osteoporosis between 2009 and 2011 were evaluated. The FRAX® model ...

ba0001pp379 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Where and when do hip fractures occur? A population-based study

Leavy Breiffni , Aberg Anna Cristina , Melhus Hakan , Mallmin Hans , Michaelsson Karl , Byberg Liisa

Purpose: To describe the timing and whereabouts of the hip fracture patient at the time of fracture in a population-based setting and to relate these factors with residential and health status, seasonal variation and snow-covered ground.Methods: We consecutively included 486 hip fracture cases (age ≥50 years) admitted to a Swedish Orthopedic Department during a 1-year period. Data concerning socio-demographic details, fall location, time of fractur...

ba0001pp497 | Other diseases of bone and mineral metabolism | ECTS2013

A frameshift mutation in receptor activator of NF-κB reveals a potential ligand-independent mechanism for NF-κB activation

Dignan Cahal , Mellis David , Duthie Angela , Pangrazio Alessandra , Sobacchi Cristina , Schulz Ansgar , Helfrich Miep , Crockett Julie

Osteoclast-poor autosomal recessive osteopetrosis is characterised by susceptibility to fracture despite high bone mineral density as a consequence of an absence of osteoclasts. One of the 12 receptor activator of NF-κB (RANK) mutations associated with this condition is a frameshift mutation encoding a protein that is truncated within the extracellular, N-terminal domain (R110Pfs). We investigated the effect of this mutation on osteoclast formation, receptor localisation ...

ba0002p94 | (1) | ICCBH2013

Bone anomalies in Noonan syndrome

Bodescu Ioana , Rusu Cristina , Idriceanu Jeanina , Vasiliu Ioana , Vulpoi Carmen , Constantinescu Georgiana

Background: Noonan syndrome (NS) is a genetic multisystem disorder characterized by distinctive facial features, learning difficulties, short stature, and cardiac defects. Other important findings include skeletal anomalies, especially spinal and chest deformities. Skeletal dysplasia was proven to be secondary to a disorder of RAS-mitogen activated protein kinase (MAPK) pathway which is essential for regulation of cell differentiation and growth including bone homeostasis. We ...

ba0002p138 | (1) | ICCBH2013

Rare mutations associated with osteoclast-poor osteopetrosis provide molecular insights into receptor activator of NFκβ signalling

Crockett Julie , Das Subhajit , Dignan Cahal , Mellis David , Duthie Angela , Sobacchi Cristina , Schulz Ansgar , Helfrich Miep

Twelve different mutations in TNFRSF11A (encoding the RANK receptor) have been associated with osteoclast-poor autosomal recessive osteopetrosis in patients. Two truncated RANK proteins resulting from substitution mutations (W434X and G280X), identified in two infants, cause loss of the intracellular oligomerisation motif and in the case of the G280X mutation the TRAF6 binding domain. A third mutation was identified in a 10-year-old patient and is a frameshift mutatio...

ba0003pp83 | Bone development/growth and fracture repair | ECTS2014

Serum serotonin: useful for the assessment of the bone metabolism status?

Poiana Catalina , Carsote Mara , Radoi Valentin , Mihai Alexandra , Geleriu Andreea , Capatana Cristina , Trifanescu Raluca , Opris Daniela

Introduction: Atypical markers will provide interesting information in order to assess the bone metabolism. Serotonin has a dual action related to the bone and its serum level is the easiest to use in daily clinical practice also the exact value is not very well described up to this moment.Aim: We correlate to serum levels of serotonin with different results of clinical bone health evaluation in menopausal women.Materials and metho...

ba0003pp305 | Osteoporosis: treatment | ECTS2014

Treatment with PTH 1--84 influences glucose metabolism trough undercarboxylated osteocalcin

D'Amelio Patrizia , Spertino Elena , Sassi Francesca , Buondonno Ilaria , Tamone Cristina , Piano Simonetta , Isaia Giovanni Carlo

In the recent years the role of the skeleton in glucose and energy homeostasis has been studied. In particular the osteoblast-specific protein osteocalcin (OC), in its undercarboxylated form (uOC) has been shown to influence glucose homeostasis in animal models.The aim of our study is to evaluate if the intermittent administration of 1–84 PTH could influence glucose metabolism through its anabolic action on the skeleton.We enr...